Annual SG&A
$21.14 M
-$467.30 K-2.16%
31 December 2023
Summary:
Co-Diagnostics annual selling, general & administrative expenses is currently $21.14 million, with the most recent change of -$467.30 thousand (-2.16%) on 31 December 2023. During the last 3 years, it has risen by +$8.20 million (+63.32%). CODX annual SG&A is now -15.26% below its all-time high of $24.95 million, reached on 31 December 2021.CODX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$5.35 M
+$1.17 M+28.12%
30 September 2024
Summary:
Co-Diagnostics quarterly selling, general & administrative expenses is currently $5.35 million, with the most recent change of +$1.17 million (+28.12%) on 30 September 2024. Over the past year, it has increased by +$295.00 thousand (+5.84%). CODX quarterly SG&A is now -35.75% below its all-time high of $8.32 million, reached on 30 June 2021.CODX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$34.44 M
-$41.28 M-603.07%
30 September 2024
Summary:
Co-Diagnostics TTM selling, general & administrative expenses is currently -$34.44 million, with the most recent change of -$41.28 million (-603.07%) on 30 September 2024. Over the past year, it has dropped by -$56.24 million (-257.98%). CODX TTM SG&A is now -114.05% below its all-time high of $26.39 million, reached on 31 March 2022.CODX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CODX Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -2.2% | +5.8% | -258.0% |
3 y3 years | +63.3% | -25.4% | -236.3% |
5 y5 years | +346.3% | +304.1% | -830.3% |
CODX Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -15.3% | +63.3% | -25.4% | +35.7% | -114.0% | at low |
5 y | 5 years | -15.3% | +363.7% | -35.8% | +317.9% | -114.0% | +64.0% |
alltime | all time | -15.3% | +2200.4% | -35.8% | +2454.8% | -114.0% | +64.0% |
Co-Diagnostics Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $5.35 M(+28.1%) | $19.92 M(+1.5%) |
June 2024 | - | $4.17 M(-6.9%) | $19.63 M(-6.1%) |
Mar 2024 | - | $4.48 M(-24.3%) | $20.90 M(-1.1%) |
Dec 2023 | $21.14 M(-2.2%) | $5.92 M(+17.2%) | $21.14 M(-3.0%) |
Sept 2023 | - | $5.05 M(-7.2%) | $21.80 M(-2.1%) |
June 2023 | - | $5.45 M(+15.4%) | $22.26 M(+7.3%) |
Mar 2023 | - | $4.72 M(-28.3%) | $20.75 M(-4.0%) |
Dec 2022 | $21.61 M(-13.4%) | $6.58 M(+19.4%) | $21.61 M(+6.2%) |
Sept 2022 | - | $5.51 M(+39.9%) | $20.35 M(-7.5%) |
June 2022 | - | $3.94 M(-29.3%) | $22.01 M(-16.6%) |
Mar 2022 | - | $5.57 M(+4.8%) | $26.39 M(+5.8%) |
Dec 2021 | $24.95 M(+92.7%) | $5.32 M(-25.8%) | $24.95 M(-1.2%) |
Sept 2021 | - | $7.17 M(-13.8%) | $25.26 M(+19.8%) |
June 2021 | - | $8.32 M(+101.3%) | $21.09 M(+37.4%) |
Mar 2021 | - | $4.13 M(-26.6%) | $15.35 M(+18.6%) |
Dec 2020 | $12.94 M | $5.63 M(+87.6%) | $12.94 M(+50.7%) |
Sept 2020 | - | $3.00 M(+16.3%) | $8.59 M(+24.3%) |
June 2020 | - | $2.58 M(+49.4%) | $6.91 M(+28.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | $1.73 M(+35.1%) | $5.39 M(+18.2%) |
Dec 2019 | $4.56 M(-3.7%) | $1.28 M(-3.3%) | $4.56 M(-3.3%) |
Sept 2019 | - | $1.32 M(+24.8%) | $4.72 M(-0.2%) |
June 2019 | - | $1.06 M(+18.2%) | $4.72 M(+1.4%) |
Mar 2019 | - | $896.50 K(-37.6%) | $4.66 M(-1.7%) |
Dec 2018 | $4.74 M(+34.5%) | $1.44 M(+7.9%) | $4.74 M(+5.2%) |
Sept 2018 | - | $1.33 M(+34.0%) | $4.50 M(-4.1%) |
June 2018 | - | $992.60 K(+1.6%) | $4.70 M(+11.5%) |
Mar 2018 | - | $977.30 K(-18.7%) | $4.21 M(+19.5%) |
Dec 2017 | $3.52 M(+283.3%) | $1.20 M(-21.1%) | $3.52 M(+37.3%) |
Sept 2017 | - | $1.52 M(+200.3%) | $2.56 M(+104.5%) |
June 2017 | - | $507.10 K(+74.9%) | $1.25 M(+31.1%) |
Mar 2017 | - | $290.00 K(+18.4%) | $956.50 K(-46.7%) |
Dec 2016 | $919.00 K(-18.5%) | $244.90 K(+15.4%) | $1.79 M(+15.8%) |
Sept 2016 | - | $212.30 K(+1.4%) | $1.55 M(+15.9%) |
June 2016 | - | $209.30 K(-81.4%) | $1.34 M(+18.6%) |
Mar 2016 | - | $1.13 M | $1.13 M |
Dec 2015 | $1.13 M | - | - |
FAQ
- What is Co-Diagnostics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Co-Diagnostics?
- What is Co-Diagnostics annual SG&A year-on-year change?
- What is Co-Diagnostics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Co-Diagnostics?
- What is Co-Diagnostics quarterly SG&A year-on-year change?
- What is Co-Diagnostics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Co-Diagnostics?
- What is Co-Diagnostics TTM SG&A year-on-year change?
What is Co-Diagnostics annual selling, general & administrative expenses?
The current annual SG&A of CODX is $21.14 M
What is the all time high annual SG&A for Co-Diagnostics?
Co-Diagnostics all-time high annual selling, general & administrative expenses is $24.95 M
What is Co-Diagnostics annual SG&A year-on-year change?
Over the past year, CODX annual selling, general & administrative expenses has changed by -$467.30 K (-2.16%)
What is Co-Diagnostics quarterly selling, general & administrative expenses?
The current quarterly SG&A of CODX is $5.35 M
What is the all time high quarterly SG&A for Co-Diagnostics?
Co-Diagnostics all-time high quarterly selling, general & administrative expenses is $8.32 M
What is Co-Diagnostics quarterly SG&A year-on-year change?
Over the past year, CODX quarterly selling, general & administrative expenses has changed by +$295.00 K (+5.84%)
What is Co-Diagnostics TTM selling, general & administrative expenses?
The current TTM SG&A of CODX is -$34.44 M
What is the all time high TTM SG&A for Co-Diagnostics?
Co-Diagnostics all-time high TTM selling, general & administrative expenses is $26.39 M
What is Co-Diagnostics TTM SG&A year-on-year change?
Over the past year, CODX TTM selling, general & administrative expenses has changed by -$56.24 M (-257.98%)